Details der Publikation - This study tests how well tolerated and effective different doses of BB2603 are as a local spray treatment in patients with Fungal Nail Infection of the toenail

This study tests how well tolerated and effective different doses of BB2603 are as a local spray treatment in patients with Fungal Nail Infection of the toenail : A Multi-Centre, International, Randomised, Vehicle Controlled, Parallel-Group, Double-Blinded Phase 2 Trial of BB2603 Topical Treatment in Subjects with Distal Subungual Onychomycosis (DSO) of the Toenail

Medienart:	Klinische Studie

Erscheinungsjahr:	2023
Erschienen:	2023

Enthalten in:	WHO International Clinical Trials Registry Platform - (2023) vom: 21. Juni Zur Gesamtaufnahme - year:2023

Sprache:	Englisch

Links:	Volltext [kostenfrei]

Themen:	610 Medical Condition: Distal Subungual Onychomycosis (DSO) of the Toenail MedDRA version: 20.0Level: PTClassification code 10030338Term: OnychomycosisSystem Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17] Phase: Phase 2 Recruitment Status: Authorised-recruitment may be ongoing or finished Study Type: Interventional

Anmerkungen:	WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 26-09-2019, Last updated: 2023-06-29

ICTRP ID:	EUCTR2019-002098-68-PL BBTAF202 2019-002098-68-DE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):	CTG004545044

Internformat


LEADER	01000caa a22002652 4500
001	CTG004545044
003	DE-627
005	20230629100626.0
007	cr uuu---uuuuu
008	210507s2023 xx \|\|\|\|\|o 00\| \|\|eng c
035			\|a (DE-627)CTG004545044
035			\|a (UBBS_Klinische_Studien_WHO)EUCTR2019-002098-68-PL
035			\|a (UBBS_Klinische_Studien_WHO)BBTAF202
035			\|a (UBBS_Klinische_Studien_WHO)2019-002098-68-DE
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a This study tests how well tolerated and effective different doses of BB2603 are as a local spray treatment in patients with Fungal Nail Infection of the toenail \|b A Multi-Centre, International, Randomised, Vehicle Controlled, Parallel-Group, Double-Blinded Phase 2 Trial of BB2603 Topical Treatment in Subjects with Distal Subungual Onychomycosis (DSO) of the Toenail
264		1	\|c 2023
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 26-09-2019, Last updated: 2023-06-29
650		4	\|a Medical Condition: Distal Subungual Onychomycosis (DSO) of the Toenail MedDRA version: 20.0Level: PTClassification code 10030338Term: OnychomycosisSystem Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
650		4	\|a Study Type: Interventional
650		4	\|a Phase: Phase 2
650		4	\|a Recruitment Status: Authorised-recruitment may be ongoing or finished
650		4	\|a 610
773	0	8	\|i Enthalten in \|t WHO International Clinical Trials Registry Platform \|g (2023) vom: 21. Juni
773	1	8	\|g year:2023 \|g day:21 \|g month:06
856	4	0	\|u https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-002098-68 \|z kostenfrei \|3 Volltext
912			\|a GBV_CTG
951			\|a AR
952			\|j 2023 \|b 21 \|c 06

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände